MedTrace Logo

Effects of Task-Based Mirror Therapy for Post-stroke Shoulder-Hand Syndrome

NCT07428811 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-02-24

No results posted yet for this study

Summary

The study aims to determine the effects of task-based mirror therapy on edema, pain and upper limb motor function with shoulder-hand syndrome in post stroke patients.

This randomized clinical trial will take place at Ittefaq Hospital and Trust Lahore and Alara healthcare clinic, Lahore involving 34 participants aged 45-75 years. Using a non-probability convenience sampling method, participants will be randomly assigned by online randomizing tool into two groups: experimental group (17 participants) and control group (17 participants). Both groups will undergo treatment for 30 minutes a day, five days a week, over four weeks. Each task will be performed by repeating each movement 20 times per set for three sets, with a 2-minute break between sets. There will also be 2-minute intervals between each completed task Outcome measures will include pain intensity assessed by the Numeric Pain Rating Scale (NPRS), edema measured by the figure-of-eight method, and upper limb motor function evaluated using the Functional Independence measure (FIM). Assessments will occur at baseline and post-intervention.

Conditions

Interventions

OTHER

Task based mirror therapy

Group A will undergo treatment for 30 minutes a day, five days a week, over four weeks. Each task will be performed by repeating each movement 20 times per set for three sets, with a 2-minute break between sets. There will also be 2-minute intervals between each completed task

OTHER

Conventional exercises

Group B will undergo treatment for 30 minutes a day, five days a week, over four weeks. Each task will be performed by repeating each movement 20 times per set for three sets, with a 2-minute break between sets. There will also be 2-minute intervals between each completed task

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Binash Afzal, PHD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-05
Primary Completion
2026-04-12
Completion
2026-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07428811 on ClinicalTrials.gov